Emergency cesarean section in glanzmann thrombasthenia: Anaesthetic management without recombinant factor VIIa

被引:0
|
作者
Priyanka, Andal [1 ]
Arulprakasam, Santhosh [1 ]
Rudingwa, Priya [1 ]
机构
[1] Jawaharlal Inst Postgrad Med Educ & Res, Dept Anaesthesiol & Crit Care, Pondicherry, India
关键词
Glanzmann thrombasthenia; pregnancy; rFVIIa; tranexamic acid;
D O I
10.4103/sja.sja_753_22
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Glanzmann thrombasthenia (GT) is a congenital disorder inherited autosomal recessively, caused by deficiency of platelet membrane glycoprotein IIb-IIIa complex leading to defective platelet aggregation, and manifesting as mucocutaneous bleeding. Parturients with GT requiring emergency cesarean section are at high risk for perioperative bleeding complications. The anesthetist should be prepared with the necessary measures to control bleeding. This paper presents the successful management of a 23-year-old primigravida with GT undergoing cesarean section in a resource-limited setup where thromboelastography and recombinant factor VIIa (rFVIIa) are not available.
引用
收藏
页码:407 / 409
页数:3
相关论文
共 50 条
  • [41] Use of recombinant factor VIIa in 3 patients with inherited type I Glanzmann's thrombasthenia undergoing inversive procedures
    d'Oiron, R
    Ménart, C
    Trzeciak, MC
    Nurden, P
    Fressinaud, E
    Dreyfus, M
    Laurian, Y
    Négrier, C
    [J]. THROMBOSIS AND HAEMOSTASIS, 2000, 83 (05) : 644 - 647
  • [42] Use of recombinant factor VIIA for post-operative haemorrhage in a patient with Glanzmann's thrombasthenia and human leucocyte antigen antibodies
    Patel, RK
    Savidge, GF
    Rangarajan, S
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2001, 114 (01) : 245 - 246
  • [43] Reversal of Glanzmann's Thrombasthenia & Glycoprotein IIb/Iiia Antagonists by Combined Haemostatic Intervention with Fibrinogen Concentrate and Recombinant Factor VIIa
    Murali-Krishnan, Gayathri
    Bevan, David
    McCormick, Aine
    Rangarajan, Savita
    Sorensen, Benny
    [J]. BLOOD, 2009, 114 (22) : 542 - 542
  • [44] The Use of Recombinant Activated Factor VII in Patients with Glanzmann's Thrombasthenia
    Poon, Man-Chiu
    [J]. THROMBOSIS AND HAEMOSTASIS, 2021, 121 (03) : 332 - 340
  • [45] Administration of recombinant factor FVIIa (NovoSeven, NovoNordisk) in a patient with Glanzmann thrombasthenia
    Zyschka, A
    Elanjikal, Z
    Ettingshausen, CE
    Saguer, IM
    Linde, R
    Kreuz, W
    [J]. 34th Hemophilia Symposium, 2005, : 378 - 379
  • [46] CASE REPORT: Successful Surgery Using Recombinant Factor VIIa for Recurrent, Idiopathic Nonulcer Duodenal Bleeding in a Patient with Glanzmann's Thrombasthenia
    Henk R. van Buuren
    Jenne J. Wielenga
    [J]. Digestive Diseases and Sciences, 2002, 47 : 2134 - 2136
  • [47] A case of glanzmann's thrombasthenia successfully treated with recombinant factor viia during a surgical procedure: observations on the monitoring and the mechanism of action of this drug
    Dargaud, Yesim
    Bordet, Jean Claude
    Trzeciak, Marie C.
    Vinciguerra, Christine
    Negrier, Claude
    [J]. HAEMATOLOGICA, 2006, 91 : 58 - 61
  • [48] The effect of platelets on fibrin gel structure formed in the presence of recombinant factor VIIa in hemophilia plasma and in plasma from a patient with Glanzmann thrombasthenia
    He, S
    Ekman, GJ
    Hedner, U
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (02) : 272 - 279
  • [49] Successful treatment of Glanzmann's Thrombasthenia with recombinant activated Factor VII "NovoSeven"
    Keikhaei, Bijan
    [J]. HAEMOPHILIA, 2014, 20 : 101 - 102
  • [50] Clinical manifestations and therapeutic response to recombinant factor VII in patients with glanzmann thrombasthenia
    Naderi, M.
    Dorgalaleh, A.
    Shadi, T.
    Eshghi, P.
    Alizadeh, S.
    Varmaghani, B.
    Bamedi, T.
    [J]. HAEMOPHILIA, 2014, 20 : 83 - 84